SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)

World Medical Association Declaration of Helsinki

JAMA · 2013 · 29.4K citations

Health Professions, Health Sciences, Clinical Medicine +2

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Journal of Hepatology · 2012 · 5.2K citations

Medicine, Oncology, Surgery +12

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach, Laura Kulik, Richard S. Finn et al. · Hepatology · 2017 · 4.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

European Journal of Cancer · 2012 · 1.1K citations

Medicine, Oncology, Surgery +12

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16